News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
294 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26478)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Voyager Therapeutics Announces Proposed Offering of Common Stock
In addition, Voyager intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering.
November 7, 2017
·
4 min read
Business
MRI Interventions Reports 26% Year-Over-Year Increase in Third Quarter Procedures
Total revenue increased 6% to $1.7 million, from $1.6 million in the same period of 2016, reflecting a 12% increase in disposable sales, offset by lower capital equipment sales.
November 7, 2017
·
17 min read
Business
Flexion Therapeutics Reports Third-Quarter 2017 Financial Results and Recent Business Highlights
The Company reported a net loss of $34.2 million for the third quarter of 2017, compared to a net loss of $17.8 million for the same period of 2016.
November 7, 2017
·
12 min read
Business
Akcea Reports Financial Results and Highlights for Third Quarter 2017
The Company reported an operating loss for the three and nine months ended September 30, 2017 on a GAAP basis of $12.6 million and $83.7 million, respectively.
November 7, 2017
·
12 min read
Business
Five Prime Announces Third Quarter 2017 Results and Provides Business Update
Cash, cash equivalents and marketable securities totaled $320.8 million on September 30, 2017, compared to $421.7 million on December 31, 2016.
November 7, 2017
·
13 min read
Deals
Chesapeake IRB and Schulman IRB Merge to Establish Premier Independent Institutional Review Board for Research
Chesapeake IRB and Schulman IRB, the research industry’s two most respected IRBs, have combined to create Advarra, the premier provider of IRB, IBC and research compliance services in North America.
November 7, 2017
·
2 min read
Business
SYGNIS AG Partners With Abingdon Health to Provide Full Service Custom Lateral Flow Assay Design and Supply
SYGNIS AG under its Innova brand name today announced it has established a partnership with Abingdon Health Ltd, which will enable SYGNIS to provide its customers with full lateral flow assay development services as well as establishing SYGNIS as the preferred colloidal gold supplier to Abingdon.
November 7, 2017
·
3 min read
Business
Personalis Wins New Contract to Sequence >34,000 Whole Human Genomes for the VA’s Million Veteran Program
The company has also developed sophisticated data systems for tracking such large numbers of human genetic samples, for efficiently processing and managing the flow of many petabytes of genetic data, and for maintaining auditable quality at large scale.
November 7, 2017
·
3 min read
Biotech Beach
Cytori Therapeutics’ STAR Trial Data Accepted for Presentation at Systemic Sclerosis World Congress
The presentation will include a full data analysis, beyond the top-line results previously reported by the company in July and October 2017.
November 7, 2017
·
5 min read
BioCapital
Sterigenics International LLC Changes Name to Sotera Health LLC
The name Sotera was inspired by the Greek goddess of safety, Soteria, and reflects the Company’s unwavering commitment to global health.
November 7, 2017
·
4 min read
Previous
15 of 30
Next